| The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma CJ Ricketts, AA De Cubas, H Fan, CC Smith, M Lang, E Reznik, R Bowlby, ... Cell reports 23 (1), 313-326. e5, 2018 | 817 | 2018 |
| The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma CJ Ricketts, AA De Cubas, H Fan, CC Smith, M Lang, E Reznik, R Bowlby, ... Cell reports 23 (1), 313-326. e5, 2018 | 817 | 2018 |
| Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages A Obradovic, N Chowdhury, SM Haake, C Ager, V Wang, L Vlahos, ... Cell 184 (11), 2988-3005. e16, 2021 | 189 | 2021 |
| Dexamethasone protects auditory hair cells against TNFα-initiated apoptosis via activation of PI3K/Akt and NFκB signaling SM Haake, CT Dinh, S Chen, AA Eshraghi, TR Van De Water Hearing research 255 (1-2), 22-32, 2009 | 142 | 2009 |
| PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma XD Liu, W Kong, CB Peterson, DJ McGrail, A Hoang, X Zhang, T Lam, ... Nature communications 11 (1), 2135, 2020 | 141 | 2020 |
| Meta-analysis of clear cell renal cell carcinoma gene expression defines a variant subgroup and identifies gender influences on tumor biology AR Brannon, SM Haake, KE Hacker, RS Pruthi, EM Wallen, ME Nielsen, ... European urology 61 (2), 258-268, 2012 | 115 | 2012 |
| Hypoxia-induced epithelial to mesenchymal transition in cancer RY Hapke, SM Haake Cancer letters 487, 10-20, 2020 | 106 | 2020 |
| Dexamethasone protects organ of corti explants against tumor necrosis factor-alpha–induced loss of auditory hair cells and alters the expression levels of apoptosis-related genes CT Dinh, S Haake, S Chen, K Hoang, E Nong, AA Eshraghi, TJ Balkany, ... Neuroscience 157 (2), 405-413, 2008 | 87 | 2008 |
| Annotation of human cancers with EGFR signaling–associated protein complexes using proximity ligation assays MA Smith, R Hall, K Fisher, SM Haake, F Khalil, MB Schabath, ... Science signaling 8 (359), ra4-ra4, 2015 | 56 | 2015 |
| Biopolymer-released dexamethasone prevents tumor necrosis factor α-induced loss of auditory hair cells in vitro: implications toward the development of a drug-eluting cochlear … C Dinh, K Hoang, S Haake, S Chen, S Angeli, E Nong, AA Eshraghi, ... Otology & neurotology 29 (7), 1012-1019, 2008 | 49 | 2008 |
| Strategies to overcome therapeutic resistance in renal cell carcinoma PJ Siska, KE Beckermann, WK Rathmell, SM Haake Urologic Oncology: Seminars and Original Investigations 35 (3), 102-110, 2017 | 48 | 2017 |
| Insights into the genetic basis of the renal cell carcinomas from The Cancer Genome Atlas SM Haake, JD Weyandt, WK Rathmell Molecular Cancer Research 14 (7), 589-598, 2016 | 45 | 2016 |
| Conservation of hearing and protection of auditory hair cells against trauma-induced losses by local dexamethasone therapy: molecular and genetic mechanisms TR Van De Water, RN Abi Hachem, CT Dinh, E Bas, SM Haake, ... Cochlear implants international 11 (sup1), 42-55, 2010 | 45 | 2010 |
| β1 Integrin regulates adult lung alveolar epithelial cell inflammation EJ Plosa, JT Benjamin, JM Sucre, PM Gulleman, LA Gleaves, W Han, ... JCI insight 5 (2), 2020 | 41 | 2020 |
| Renal cancer subtypes: Should we be lumping or splitting for therapeutic decision making? SM Haake, WK Rathmell Cancer 123 (2), 200-209, 2017 | 38 | 2017 |
| Patients with ClearCode34-identified molecular subtypes of clear cell renal cell carcinoma represent unique populations with distinct comorbidities SM Haake, SA Brooks, E Welsh, WJ Fulp, DT Chen, J Dhillon, E Haura, ... Urologic Oncology: Seminars and Original Investigations 34 (3), 122. e1-122. e7, 2016 | 27 | 2016 |
| Tyrosine Kinase Signaling in Clear Cell and Papillary Renal Cell Carcinoma Revealed by Mass Spectrometry–Based Phosphotyrosine Proteomics SM Haake, J Li, Y Bai, F Kinose, B Fang, EA Welsh, R Zent, J Dhillon, ... Clinical Cancer Research 22 (22), 5605-5616, 2016 | 22 | 2016 |
| Neoadjuvant pazopanib and molecular analysis of tissue response in renal cell carcinoma CG Wood, JE Ferguson III, JS Parker, DT Moore, JG Whisenant, ... Jci Insight 5 (22), 2020 | 14 | 2020 |
| Clinical features and multiplatform molecular analysis assist in understanding patient response to anti-PD-1/PD-L1 in renal cell carcinoma E Shiuan, A Reddy, SO Dudzinski, AR Lim, A Sugiura, R Hongo, K Young, ... Cancers 13 (6), 1475, 2021 | 12 | 2021 |
| Optimal treatment by invoking biologic clusters in renal cell carcinoma (OPTIC RCC). YW Chen, K Beckermann, SM Haake, A Reddy, Y Shyr, MB Atkins, N Mar, ... Journal of Clinical Oncology 41 (6_suppl), TPS742-TPS742, 2023 | 9 | 2023 |
